BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2445907)

  • 1. Selection and characterization of interferon-sensitive cells derived from an interferon-resistant NIH 3T3 line.
    Mittnacht S; Jacobsen H
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2945-51. PubMed ID: 2445907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
    Mittnacht S; Jacobsen H
    Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus.
    Gribaudo G; Lembo D; Cavallo G; Landolfo S; Lengyel P
    J Virol; 1991 Apr; 65(4):1748-57. PubMed ID: 1705989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.
    Kumar R; Choubey D; Lengyel P; Sen GC
    J Virol; 1988 Sep; 62(9):3175-81. PubMed ID: 2841470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication.
    Coccia EM; Romeo G; Nissim A; Marziali G; Albertini R; Affabris E; Battistini A; Fiorucci G; Orsatti R; Rossi GB
    Virology; 1990 Nov; 179(1):228-33. PubMed ID: 2171206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system.
    Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M
    J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of macrophage growth and antiviral activity by interferon-gamma.
    Goldberg M; Belkowski LS; Bloom BR
    J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2'-5')oligoadenylate synthetase activity.
    Salzberg S; Wreschner DH; Oberman F; Panet A; Bakhanashvili M
    Mol Cell Biol; 1983 Oct; 3(10):1759-65. PubMed ID: 6646121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon inducibility and sensitivity of human teratocarcinoma-derived cell lines.
    Ogunkolade W; Canivet M; Pochart F; Fourcade A; Chousterman S; Hovanessian A; Peries J
    J Interferon Res; 1987 Jun; 7(3):245-54. PubMed ID: 2440957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 2-5A synthetase expression by antisense RNA interferes with interferon-mediated antiviral and antiproliferative effects and induces anchorage-independent cell growth.
    Yaffe A; Schwarz Y; Hacohen D; Kinar Y; Nir U; Salzberg S
    Cell Growth Differ; 1996 Aug; 7(8):969-78. PubMed ID: 8853892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication.
    Díaz-Guerra M; Rivas C; Esteban M
    Virology; 1997 Jan; 227(1):220-8. PubMed ID: 9007077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antiviral effects of interferon in three murine cell lines.
    Sen GC; Herz RE
    J Virol; 1983 Mar; 45(3):1017-27. PubMed ID: 6187940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of vaccinia virus to interferons: modulation of the 2-5A system in interferon-treated, vaccinia virus infected cells.
    Páez E; Esteban M
    Microbiologia; 1987 Oct; 3(3):163-78. PubMed ID: 2478164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferons-alpha/beta- and -gamma-resistant Friend cell variants exhibiting receptor sites for interferons but no induction of 2-5A synthetase and 67K protein kinase.
    Coccia EM; Federico M; Romeo G; Affabris E; Cofano F; Rossi GB
    J Interferon Res; 1988 Feb; 8(1):113-27. PubMed ID: 2966842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical analysis of mutants of a macrophage cell line resistant to the growth-inhibitory activity of interferon.
    Nagata Y; Rosen OM; Makman MH; Bloom BR
    J Cell Biol; 1984 Apr; 98(4):1342-7. PubMed ID: 6325469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon.
    Whitaker-Dowling P; Youngner JS
    Virology; 1986 Jul; 152(1):50-7. PubMed ID: 2424172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse cell line, which is unprotected by interferon against lytic virus infection, lacks ribonuclease F activity.
    Epstein DA; Czarniecki CW; Jacobsen H; Friedman RM; Panet A
    Eur J Biochem; 1981 Aug; 118(1):9-15. PubMed ID: 6169526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection.
    Li XL; Blackford JA; Hassel BA
    J Virol; 1998 Apr; 72(4):2752-9. PubMed ID: 9525594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interferon on two human choriocarcinoma-derived cell lines.
    Vandenbussche P; Kuwata T; Verhaegen-Lewalle M; Content J
    Virology; 1983 Jul; 128(2):474-9. PubMed ID: 6310868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells.
    Czarniecki CW; Sreevalsan T; Friedman RM; Panet A
    J Virol; 1981 Feb; 37(2):827-31. PubMed ID: 6163874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.